Try our beta test site
1 study found for:    NCT00568750
Show Display Options
Rank Status Study
1 Active, not recruiting Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib

Study has passed its completion date and status has not been verified in more than two years.